These findings appear to parallel those reported for ER+ breast cancer where decreased expression of CYP7B1 and increased CYP27A1 has been reported in tumours compared to normal breast tissues (Wu et al. 2013). The gene discussed is CYP27A1; the disease is breast carcinoma.